These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1301028)

  • 1. Drugs and the exercise test.
    Muir KW; Rodger JC; DeBono JS; McDonald H; Irving JB
    BMJ; 1992 Oct; 305(6857):808-9. PubMed ID: 1301028
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs and exercise testing.
    Millane T; Ward D
    BMJ; 1992 Oct; 305(6861):1043. PubMed ID: 1467680
    [No Abstract]   [Full Text] [Related]  

  • 3. Heart medications: indications and interactions in stress testing.
    Duncan BH; Sillaman LE
    J Nucl Cardiol; 1999; 6(3):357-61. PubMed ID: 10385191
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ergospirometry in the evaluation of cardiovascular drugs].
    Kleber FX; Doering W
    Z Kardiol; 1994; 83 Suppl 3():89-96. PubMed ID: 7941678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular drugs: effects on exercise testing and exercise training of the coronary patient.
    Wenger NK
    Cardiovasc Clin; 1985; 15(2):133-43. PubMed ID: 2868791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An evaluation of the role of paired loading tests in selecting the long-term drug therapy for patients with stable angina].
    Voronkov LG; Sokolov NF; Sharaeva ML; Kuts' VA; Lomakovskiĭ AN
    Kardiologiia; 1993; 33(10):12-5, 3. PubMed ID: 8139163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differences in the treatment plans of hospitals. Use of antidiabetics and selected cardiovascular drugs at 20 hospitals].
    Haugen O; Hjort PF; Andrew M; Oydvin K
    Tidsskr Nor Laegeforen; 1980 Jun; 100(16):1065-8. PubMed ID: 7414586
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular drugs in Australian hospitals.
    McManus P
    Med J Aust; 1992 Nov; 157(10):717. PubMed ID: 1435429
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vasoactive drugs in peripheral arterial perfusion disorders. Problems, principles and results of the determination of therapeutic efficacy].
    Heidrich H
    Dtsch Med Wochenschr; 1985 Aug; 110(31-32):1219-24. PubMed ID: 3926447
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of the prostacyclin analog taprostene on ischemic ST-segment depression in the stress ECG of coronary patients].
    Hopf R; Schöfl E; Frings M; Söhngen W
    Z Kardiol; 1994 Apr; 83(4):258-63. PubMed ID: 8023538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silent ischaemia: to treat or not to treat?
    Deedwania PC
    Indian Heart J; 1996; 48(4):415-9. PubMed ID: 8908836
    [No Abstract]   [Full Text] [Related]  

  • 12. The 2014 American Heart Association/American College of Cardiology guideline for the management of patients with valvular heart disease: a changing landscape.
    Neely RC; Leacche M; Gosev I; Kaneko T; Byrne JG; Davidson MJ
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):5-6. PubMed ID: 24939018
    [No Abstract]   [Full Text] [Related]  

  • 13. [The prognosis of the antianginal effect of foridon compared to other antianginal preparations].
    Shkarin VV; Naumova NA; Naumov VG
    Kardiologiia; 1993; 33(3):48-51. PubMed ID: 8377339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How efficacy of antianginal drugs should be evaluated].
    Kośmicki M; Kowalik I; Sadowski Z
    Przegl Lek; 2000; 57(7-8):411-4. PubMed ID: 11109316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The individual choice of anti-anginal preparations by using paired bicycle ergometry tests in patients with stenocardia].
    Metelitsa VI; Kokurina EV; Bochkareva EV
    Ter Arkh; 1992; 64(9):35-9. PubMed ID: 1362293
    [No Abstract]   [Full Text] [Related]  

  • 16. [Silent myocardial ischemia].
    Boehringer K; Nager F
    Schweiz Rundsch Med Prax; 1988 May; 77(18):481-2. PubMed ID: 3175404
    [No Abstract]   [Full Text] [Related]  

  • 17. Hospitals are wrong to ban e-cigarette use.
    Shaw D
    BMJ; 2015 Sep; 351():h5063. PubMed ID: 26423310
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular disease in women: heart disease across the life span.
    Madrazo C
    FP Essent; 2013 Aug; 411():16-22. PubMed ID: 23977827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical use of prostacyclin and its analogs in coronary vasculopathy].
    Lenzi S; Bugiardini R
    Ann Ital Med Int; 1986 Jun; 1(2):141-51. PubMed ID: 2484319
    [No Abstract]   [Full Text] [Related]  

  • 20. [The use of mildronat with stenocardia patients].
    Dudko VA; Koshel'skaia OA; Sokolov AA
    Vrach Delo; 1989 Oct; (10):64-7. PubMed ID: 2694612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.